These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 23658482

  • 1. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W.
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [Abstract] [Full Text] [Related]

  • 2. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS.
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [Abstract] [Full Text] [Related]

  • 3. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S, Koli U, Dharamdasani V, Jain R, Dandekar P.
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N, Alam MA, Ahmad R, Naqvi AA, Ahmad FJ.
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [Abstract] [Full Text] [Related]

  • 5. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 6. Permeability of exendin-4-loaded chitosan nanoparticles across MDCK cell monolayers and rat small intestine.
    Wang M, Zhang Y, Sun B, Sun Y, Gong X, Wu Y, Zhang X, Kong W, Chen Y.
    Biol Pharm Bull; 2014 Feb 01; 37(5):740-7. PubMed ID: 24789997
    [Abstract] [Full Text] [Related]

  • 7. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K, Yamamoto H, Hirashima N, Kawashima Y.
    Eur J Pharm Biopharm; 2010 Mar 01; 74(3):421-6. PubMed ID: 20034563
    [Abstract] [Full Text] [Related]

  • 8. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P, Xu Y, Zeng C, Ren H, Peng M.
    Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597
    [Abstract] [Full Text] [Related]

  • 9. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y, Xie XY, Mei XG.
    Drug Deliv; 2016 Aug 30; 23(3):787-93. PubMed ID: 24870204
    [Abstract] [Full Text] [Related]

  • 10. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.
    Pharm Res; 2010 Jul 30; 27(7):1285-95. PubMed ID: 20309616
    [Abstract] [Full Text] [Related]

  • 11. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.
    Guo C, Gemeinhart RA.
    Eur J Pharm Biopharm; 2008 Oct 30; 70(2):597-604. PubMed ID: 18602994
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J.
    Eur J Pharm Sci; 2012 Apr 11; 45(5):632-8. PubMed ID: 22248882
    [Abstract] [Full Text] [Related]

  • 13. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V, Bernkop-Schnürch A.
    Drug Dev Ind Pharm; 2007 Jul 11; 33(7):767-74. PubMed ID: 17654025
    [Abstract] [Full Text] [Related]

  • 14. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N, Alam MA, Ahmad R, Umar S, Jalees Ahmad F.
    J Microencapsul; 2018 Jun 11; 35(4):327-343. PubMed ID: 29873288
    [Abstract] [Full Text] [Related]

  • 15. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]

  • 16. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
    Abd El Hady WE, Mohamed EA, Soliman OAE, El-Sabbagh HM.
    Int J Nanomedicine; 2019 Jul 22; 14():7191-7213. PubMed ID: 31564873
    [Abstract] [Full Text] [Related]

  • 17. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
    Kang BS, Choi JS, Lee SE, Lee JK, Kim TH, Jang WS, Tunsirikongkon A, Kim JK, Park JS.
    Carbohydr Polym; 2017 Mar 01; 159():39-47. PubMed ID: 28038752
    [Abstract] [Full Text] [Related]

  • 18. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 01; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 19. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 20. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y.
    Biomaterials; 2011 Jan 01; 32(3):870-8. PubMed ID: 20934748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.